Bacillus coagulans alleviates hepatic injury caused by Klebsiella pneumoniae in rabbits

PLoS One. 2025 Jan 10;20(1):e0317252. doi: 10.1371/journal.pone.0317252. eCollection 2025.

Abstract

Background: As an opportunistic bacterial pathogen, Klebsiella pneumoniae (KP) is prone to causing a spectrum of diseases in rabbits when their immune system is compromised, which poses a threat to rabbit breeding industry. Bacillus coagulans (BC), recognized as an effective probiotic, confers a variety of benefits including anti-inflammatory and antioxidant properties.

Aim: The purpose of this study was to investigate whether dietary BC can effectively alleviate hepatic injury caused by KP.

Methods: In this study, the rabbits were initially pretreated with varying doses of BC (1×106, 5×106, and 1×107 CFU/g), followed by a challenge with KP at a concentration of 1011 CFU/mL. Liver tissues were harvested and processed for histological assessment using H&E and VG stains to assess structural alterations. Biochemical assays were employed to quantify the enzymatic activities of T-SOD and GSH-Px, as well as the MDA content. Furthermore, ELISA was utilized to detect the levels of inflammatory cytokine (IL-10, IL-6, IL-1β and TNF-α) and apoptotic-related gene (Bcl-2, Bax).

Results: Morphological observation indicated that BC can effectively mitigate KP-induced hepatic sinusoidal dilatation and congestion, as well as ameliorate the degree of hepatic fibrosis. Further analysis showed that BC significantly lowered MDA level in KP-treated rabbits, while enhanced the activities of T-SOD and GSH-Px. Additionally, ELISA result showed that BC pretreatment significantly reduced the levels of pro-inflammatory cytokines TNF-a, IL-6, IL-1β and pro-apoptotic gene Bax, while increasing the levels of anti-inflammatory cytokine IL-10 and anti-apoptotic gene Bcl-2 in KP-treated rabbits.

Conclusion: Above data indicate that BC supplementation effectively attenuated oxidative stress and inflammatory response induced by KP through augmenting the activities of antioxidant enzymes and diminishing the levels of pro-inflammatory factors. Furthermore, it reduced the Bax/Bcl-2 ratio in the liver, thereby inhibiting KP-induced apoptosis. The treatment group receiving 5x106 CFU/g BC benefitted most from the protective effect.

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Bacillus coagulans*
  • Cytokines / metabolism
  • Klebsiella Infections / drug therapy
  • Klebsiella pneumoniae*
  • Liver* / drug effects
  • Liver* / metabolism
  • Liver* / pathology
  • Male
  • Oxidative Stress / drug effects
  • Probiotics* / administration & dosage
  • Probiotics* / pharmacology
  • Rabbits

Substances

  • Cytokines

Grants and funding

This research was funded by the University-Enterprise Horizontal Cooperation Project (20220084,20210018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.